Advertisement

Topics

ICON Clinical Research Ltd Company Profile

14:42 EST 17th December 2018 | BioPortfolio

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the management, execution and analysis of clinical trials ranging from small, focused studies to complex, multinational projects.
In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.

Location

212 Church Road
North Wales
Massachusetts
19454
United States of America

Contact

Phone: 1 215 616 3000
Fax: 1 215 699 6288
Email: info@iconus.com


News Articles [717 Associated News Articles listed on BioPortfolio]

Icon launches technology for adaptive clinical trial design

Icon has launched an integrated technology platform for the design, simulation, and analysis of adaptive clinical trials.

ICON Announces Plans to Expand Hospital-based Presence for Translational Medicine

ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced plans to furthe...

Robotics, automation to play a ‘fundamental role’ in Icon’s continued success: Q2 earnings call

Robotics and automation will help improve the clunky and expensive clinical trial process, says Icon CEO â as the company continues to evaluate potential opportunities to improve efficiency.

New Icon collab looks to meet demand for real world evidence

Icon and Practice Fusion have teamed up to meet the expanding demand for real world evidence â and aim to transform the way research is conducted.

R B and Pop Icon Valerie Simpson and Pulitzer Prize-Winning Composer Melinda Wagner Receive Top ...

NEW YORK, Dec. 12, 2018 /PRNewswire/ -- The ASCAP Foundation honored R&B and pop icon Valerie Simpson with its George M. Cohan Friars Foundation Award Read more...

ICON CEO: CROs Must Be Aware Of Threat Posed By Big Tech

ICON’s CEO Steve Cutler talks candidly about the impact of biotech funding, disruptive tech providers, and the constant pressure of...   

Icon reports record awards in Q3, outlines 3-part patient recruitment strategy

Icon reported a record number of new business awards in Q3 and outlined its three-part patient recruitment strategy as well as global hiring â and acquiring â plans.

ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical devi

PubMed Articles [4108 Associated PubMed Articles listed on BioPortfolio]

Quality assurance tests for the Gamma Knife Icon™ image guidance system.

The Gamma Knife Icon™ comes with an image guidance system for tracking patient motion and correcting for inter- and intrafractional shifts, mainly used with frameless thermoplastic immobilization. T...

A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

This phase 1 study evaluated the safety and tolerability of single intravitreous injections (IVIs) of ICON-1 (Iconic Therapeutics, South San Francisco, CA) in patients with neovascular age-related mac...

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study.

The Institute of Medicine has called for approaches to help maximize the return on investments (ROI) in cancer clinical trials. Value of Research (VOR) is a health economics technique that estimates R...

Evolution of Research Ethics in a Low Resource Setting: a case of Uganda.

The globalization of clinical research in the last two decades has led to a significant increase in the volume of clinical research in developing countries. As of 2016, Uganda was the third largest de...

Frontiers in pigment cell and melanoma research.

In this perspective, we identify emerging frontiers in clinical and basic research of melanocyte biology and its associated biomedical disciplines. We describe challenges and opportunities in clinical...

Clinical Trials [3291 Associated Clinical Trials listed on BioPortfolio]

The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances

The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate the safety and effects of repeated intravitreal injections of ICON-1 0.6 mg administered as maintenance therapy or in combination with aflibercept ...

Randomized Controlled Crossover Comparison of Icon Underwear to Disposable Pads

This is a randomized cross over trial to compare quality of life and product performance between Icon reusable underwear versus standard disposable pad in patients with mild to moderate ur...

Non-invasive Monitor in Endoscopic Invasive Procedure

We include the patients who need painless invasive endoscopic precedure, we collect the dempgraphic data and apply the non-invasive device ICON on patients during the who procedure.

Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation

The aim of the study is to investigate the use of a new FDA-approved non-invasive bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in children undergoing ...

Companies [3300 Associated Companies listed on BioPortfolio]

ICON Clinical Research

ICON was founded in 1990 by a group of experienced professionals, who were dedicated to providing the pharmaceutical and biotechnology industries with exceptional clinical research and biometric servi...

ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic devel...

ICON plc.

ICON plc. is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic deve...

Iconic Therapeutics

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal di...

ICON Eyecare

ICON Eyecare is a leading surgical and medical eye care provider, based out of Denver, CO. Since 1999, ICON has been building a Center of Ophthalmology Excellence empowered by an ...

More Information about "ICON Clinical Research Ltd" on BioPortfolio

We have published hundreds of ICON Clinical Research Ltd news stories on BioPortfolio along with dozens of ICON Clinical Research Ltd Clinical Trials and PubMed Articles about ICON Clinical Research Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ICON Clinical Research Ltd Companies in our database. You can also find out about relevant ICON Clinical Research Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record